期刊文献+

Foxp3基因及调节性T细胞在重症肌无力被动转移幼鼠发病中的作用机制 被引量:6

Role of Foxp3 and regulatory T cells in pathogenesis of passive transferred myasthenia gravis in young mice
下载PDF
导出
摘要 目的探讨Foxp3+CD4+CD25+调节性T细胞、Foxp3mRNA在重症肌无力被动转移模型(passive transferred myasthenia gravis,PTMG)发病中的作用机制。方法将16只幼年雌性C57BL/6小鼠随机分为2组:模型组和对照组,模型组经腹腔注射含1.0mg/kgmAb35的Ringer's液0.2ml建立PTMG模型,正常对照组注射不含mAb35的Ringer's液0.2ml。采用流式细胞技术检测小鼠脾细胞中CD4+CD25+T细胞及Foxp3+CD4+CD25+Tregs含量,实时荧光定量聚合酶链反应(RT-FQ-PCR)分析2组小鼠脾细胞中Foxp3mRNA的表达,ELISA法检测2组小鼠血清白介素-2和干扰素-γ的水平。结果①模型组小鼠脾细胞中CD4+CD25+T细胞与CD4+T细胞含量的比例与对照组比较有统计学差异[(8.82±0.74)%vs(9.89±0.88)%,P<0.05];模型组Foxp3+CD4+CD25+Tregs与CD4+CD25+T细胞含量的比例与对照组比较显著降低[(6.83±1.18)%vs(8.38±0.76)%,P<0.01];脾细胞悬液中Foxp3mRNA表达量模型组低于对照组[(0.47±0.30)vs(1.53±1.19),P<0.05];模型组小鼠血清IL-2、IFN-γ水平分别为(24.41±13.83)ng/L、(142.31±6.05)ng/L,高于对照组小鼠[(12.09±2.96)ng/L、(109.36±3.64)ng/L](P<0.05)。②模型组小鼠Foxp3+CD4+CD25+Tregs数量变化与CD4+CD25+T细胞数量呈正相关(r=0.864,P<0.01),对照组小鼠Foxp3+CD4+CD25+Tregs数量变化与CD4+CD25+T细胞数量亦呈正相关(r=0.977,P<0.01)。结论Foxp3mRNA表达下调,导致Foxp3+CD4+CD25+Tregs细胞亚群表达降低,并通过上调的IL-2和IFN-γ介导了Foxp3及Tregs在重症肌无力发病机制中的作用。 Objective To study the role of Foxp3^+ CD4^+ CD25^+ regulatory T cells ( Foxp3^+ CD4^+ CD25 ^+Tregs) and Foxp3mRNA in pathogenesis of passive transferred myasthenia gravis (PTMG) by detecting their expression in a PTMG model. Methods Sixteen C57BL/6 young female mice were divided into model group and control group. A PTMG model was established by injecting Ringer's solution containing 1.0 mg/kg mAb35 into abdominal cavity. Mice in control group were injected with Ringer's solution not containing mAb35. Levels of CD4^+ CD25^+ T cells and Foxp3^+ CD4^+ CD25^+ Tregs in spleen cells were measured by flow cytometry. Expression of Foxp3 mRNA in spleen cells was detected by real-time fluorescent quantitative polymerase chain reaction (RT-FQ-PCR). Serum level of interleukin-2 and interferon-γ/was detected by ELISA. Results The ratio of CD4^+ CD25^+ T ceils and CD^+ T ceils was higher in model group [ ( 8.82 ± 0. 74) % ] than in control group [ (9.89 ± 0.88 ) % ] ( P 〈 0.05 ). The ratio of Foxp3^+ CD4^+ CD25^+ Tregs and CD4 ^+CD25^+ T cells was significantly lower in model group [ ( 6.83 ± 1. 18 ) % ] than in control group [ ( 8.38 ± 0.76 ) % ], ( P 〈 0. 01 ). The expression level of Foxp3 mRNA in spleen cells was significantly lower in model group (0.47 ± 0. 30) than in control group (1.53 ± 1.19) (P 〈0.05). The serum level of IL-2 and IFN-γ/ was higher in model group (24.41 ± 13.83 and 142.31 ±6.05 ng/L) than in control group ( 12.09 ±2.96 and 109.36 ± 3.64 ng/L) ( P 〈 0. 05 ). The change in the number of Foxp3^+CD4^+ CD25^+ Tregs was positively correlated with that of CD4^+ CD25^+ T cells between model and control groups ( r = 0. 864 vs r = 0. 977, P 〈 0. 01 ). Conclusion Down-regulation of Foxp3 expression can decrease the expression of Foxp3^+ CD^+ CD25^+ Tregs subgroups, and up-regulation of IL-2 and IFN-γ plays an important role in the pathogenesis of Foxp3-mediated PTMG.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2010年第4期353-356,共4页 Journal of Third Military Medical University
基金 重庆市卫生局科研基金(2008-2-169)~~
关键词 重症肌无力 调节性T细胞 FOXP3 IL-2 荧光定量聚合酶链反应 小鼠 近交CSTBL myasthenia gravis regulatory T cell Foxp3 interleukin-2 real-time fluorescent quantitative polymerase chain reaction mice, inbred C57BL
  • 相关文献

参考文献11

  • 1Marson A, Kretschmer K, Frampton G M, et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation [ J ]. Nature, 2007, 445(7130) : 931 -935. 被引量:1
  • 2黄志,徐秀娟.nAChR单克隆抗体建立重症肌无力被动转移小鼠模型的研究[J].第三军医大学学报,2006,28(13):1397-1400. 被引量:9
  • 3Lennon V A, Lambert Eh, Leiby K R, et al. Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis [J]. J Immunol, 1991, 146 (7) : 2245 - 2248. 被引量:1
  • 4Fontenot J D, Rudensky A Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcfption factor Foxp3[J]. Nat Immunol, 2005, 6(4) : 331 -337. 被引量:1
  • 5Annacker O, Pimenta-Araujo R, Burlen-Defranoux O, et al. On the ontogeny and physiology of regulatory T cells [ J ]. Immunol Rev, 2001, 182:5-17. 被引量:1
  • 6Zheng S G, Wang J H, Stohl W, et al. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4^+ CD25^+ regulatory cells [ J ]. J Immunol, 2006, 176 ( 6 ) : 3321 - 3329. 被引量:1
  • 7徐秀娟,黄志.重症肌无力被动转移幼鼠的黏膜免疫耐受研究[J].中华儿科杂志,2008,46(5):366-369. 被引量:4
  • 8Ishimaru N, Kishimoto H, Hayashi Y, et al. Regulation of naive T cell function by the NF-kappaB2 pathway[J]. Nat Immunol, 2006, 7(7) : 763 - 772. 被引量:1
  • 9Zorn E, Nelson E A, Mohseni M, et al. IL-2 regulates FOXP3 expression in human CD4^+ CD25^+ regulatory T ceils through a STAT-dependent mechanism and induces the expansion of these cells in vivo [ J ]. Blood, 2006, 108(5) : 1571 -1579. 被引量:1
  • 10Karachunski P I, Ostlie N S, Monfardini C, et al. Absence of IFN- amma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice[J]. J Immunol, 2000, 164(10) : 5236 -5244. 被引量:1

二级参考文献25

  • 1黄志,徐秀娟.nAChR单克隆抗体建立重症肌无力被动转移小鼠模型的研究[J].第三军医大学学报,2006,28(13):1397-1400. 被引量:9
  • 2Souroujon MC, Maiti PK, Feferman T, et al. Suppression of myasthenia gravis by anti-specific mucosal tolerance and modulation of cytokines and costimmulatory factors. Ann N Y Acad Sci, 2003, 998:533-536. 被引量:1
  • 3Duan RS, Link H, Xiao BG. Long-term effects of IFN-gamma, IL-10, and TGF-beta- modulated dendritic cells on immune response in Lewis mrs. J Clin Immunol, 2005, 25:50-56. 被引量:1
  • 4Liu R, La Cava A, Bai XF, et aL Cooperation of invariant NKT cells and CD4^ + CD25^ + T regulatory cells in the prevention of autoimmune myasthenia. J Immunol, 2005,175:7898-7904. 被引量:1
  • 5Yamagiwa S, Gray JD, Hashimoto S, et aL A role for TGF-β in the generation and expansion of CD4 ^+ CD25^ + regulatory T Cells from human peripheral blood. J Immunol, 2001,166:7282-7289. 被引量:1
  • 6Maiti PK, Feferman T, Im SH, et aL Immunosupression of rat myasthenia gravis by oral administration of syngeneic acetylcholine receptor fragment. Neuroimmunol, 2004, 152 : 112- 120. 被引量:1
  • 7Ben-David H, Aruna BV, Seger R, et al. A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses. Proc Natl Acad Sci USA, 2006,103 : 18232-18237. 被引量:1
  • 8Poulas K, Tsouloufis T, Tzartos .l. Treatment of passively transferred experimental autoimmune myasthenia gravis using papain. Clin Exp Immunol,2000 ,120 :363-368. 被引量:1
  • 9Kaminski HJ, Li Z, Richmonds C, et aL Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis. Exp Neurol, 2004, 189:333-342. 被引量:1
  • 10Lennon VA, Lambert EH, LeVy KR, et aL Recombinant human acetychline receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis. J Immunol, 1991,146:2245-2248. 被引量:1

共引文献10

同被引文献48

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部